Treatment for Chronic Cough with CT Evidence of Bronchitis
For a patient with chronic cough and CT evidence of bronchitis, first-line treatment should be ipratropium bromide to improve cough symptoms, with a recommended dose of 36 μg (2 inhalations) four times daily. 1
First-Line Bronchodilator Therapy
- Ipratropium bromide is recommended with a grade A recommendation for improving cough in stable patients with chronic bronchitis, as it reduces cough frequency, cough severity, and volume of sputum expectorated 2, 1
- Short-acting β-agonists should be used to control bronchospasm and relieve dyspnea; in some patients, they may also reduce chronic cough (Grade A recommendation) 2, 1
- If there is no adequate response to ipratropium bromide after 2 weeks, consider adding a short-acting β-agonist for additional bronchodilation and potential cough relief 2, 1
Advanced Therapy Options
- For patients with inadequate response to first-line bronchodilators, treatment with a long-acting β-agonist coupled with an inhaled corticosteroid should be offered to control chronic cough (Grade A recommendation) 2, 1
- Theophylline should be considered to control chronic cough in stable patients with chronic bronchitis, though careful monitoring for complications is necessary (Grade A recommendation) 2
- For patients with severe airflow obstruction (FEV1 < 50% predicted) or frequent exacerbations, inhaled corticosteroid therapy should be offered 2
Management of Acute Exacerbations
- During acute exacerbations, both short-acting β-agonists and anticholinergic bronchodilators should be administered, with the addition of the other agent at maximal dose if prompt response is not observed 2, 1
- Antibiotics are recommended for acute exacerbations of chronic bronchitis, particularly for patients with severe exacerbations and those with more severe airflow obstruction at baseline (Grade A recommendation) 2, 3
- Theophylline should not be used for treatment during acute exacerbations (Grade D recommendation) 2
Important Considerations and Pitfalls
- Avoidance of respiratory irritants, particularly tobacco smoke, is essential and is the most effective means to improve or eliminate the cough of chronic bronchitis 2, 4
- Currently available expectorants have not been proven effective for stable patients with chronic bronchitis and should not be used (Grade I recommendation) 2, 5
- Long-term prophylactic therapy with antibiotics is not recommended for stable patients with chronic bronchitis due to concerns about antibiotic resistance and potential side effects (Grade I recommendation) 2, 1
- Postural drainage and chest percussion have not been proven beneficial and are not recommended for either stable patients or those with acute exacerbations of chronic bronchitis 2
- In elderly patients, chronic pulmonary changes on imaging may be incidental and not the cause of the current cough, so consider other common causes of chronic cough such as upper airway cough syndrome and gastroesophageal reflux disease 6, 4
Treatment Algorithm
- Start with ipratropium bromide 36 μg (2 inhalations) four times daily 1
- If inadequate response after 2 weeks, add short-acting β-agonist 2, 1
- For persistent symptoms or frequent exacerbations, add long-acting β-agonist with inhaled corticosteroid 2
- For acute exacerbations, use both short-acting β-agonists and anticholinergic bronchodilators, and consider antibiotics 2, 3
- Emphasize smoking cessation and avoidance of respiratory irritants throughout treatment 2, 4